OptiNose, Inc. (OPTN)

USD 9.09

(0.39%)

Operating Expenses Summary of OptiNose, Inc.

  • OptiNose, Inc.'s latest annual operating expenses in 2023 was 85.1 Million USD , down -31.09% from previous year.
  • OptiNose, Inc.'s latest quarterly operating expenses in 2024 Q2 was 24.97 Million USD , up 15.78% from previous quarter.
  • OptiNose, Inc. reported a annual operating expenses of 122.9 Million USD in annual operating expenses 2022, down -6.85% from previous year.
  • OptiNose, Inc. reported a annual operating expenses of 131.95 Million USD in annual operating expenses 2021, up 2.43% from previous year.
  • OptiNose, Inc. reported a quarterly operating expenses of 24.97 Million USD for 2024 Q2, up 15.78% from previous quarter.
  • OptiNose, Inc. reported a quarterly operating expenses of 19.29 Million USD for 2023 Q3, down -8.37% from previous quarter.

Annual Operating Expenses Chart of OptiNose, Inc. (2023 - 2015)

Historical Annual Operating Expenses of OptiNose, Inc. (2023 - 2015)

Year Operating Expenses Operating Expenses Growth
2023 85.1 Million USD -31.09%
2022 122.9 Million USD -6.85%
2021 131.95 Million USD 2.43%
2020 128.81 Million USD 3.1%
2019 124.93 Million USD 18.18%
2018 105.71 Million USD 117.84%
2017 48.53 Million USD 126.22%
2016 21.45 Million USD -22.04%
2015 27.51 Million USD 0.0%

Peer Operating Expenses Comparison of OptiNose, Inc.

Name Operating Expenses Operating Expenses Difference
Bright Green Corporation 8.25 Million USD -931.18%
Alpha Teknova, Inc. 45.85 Million USD -85.573%
ANI Pharmaceuticals, Inc. 195.98 Million USD 56.577%
Aquestive Therapeutics, Inc. 44.85 Million USD -89.731%
Collegium Pharmaceutical, Inc. 159.2 Million USD 46.547%
Cosmos Health Inc. 26.18 Million USD -225.055%
Journey Medical Corporation 54.59 Million USD -55.882%
Embecta Corp. 528.4 Million USD 83.894%
Esperion Therapeutics, Inc. 271.89 Million USD 68.701%
Dynavax Technologies Corporation 219.14 Million USD 61.166%
Intra-Cellular Therapies, Inc. 590 Million USD 85.576%
Pacira BioSciences, Inc. 326.37 Million USD 73.925%
PainReform Ltd. 9.58 Million USD -787.959%
Sunshine Biopharma, Inc. 13.12 Million USD -548.422%
Sunshine Biopharma, Inc. 13.12 Million USD -548.422%
SCYNEXIS, Inc. 51.84 Million USD -64.137%
Safety Shot Inc 12.1 Million USD -602.759%
China SXT Pharmaceuticals, Inc. 3.06 Million USD -2672.786%
Procaps Group, S.A. 199.47 Million USD 57.337%
Theratechnologies Inc. 72.75 Million USD -16.969%
Harrow Health, Inc. 89.97 Million USD 5.414%
Sonoma Pharmaceuticals, Inc. 9.44 Million USD -800.932%
Biofrontera Inc. 39.95 Million USD -112.973%
DURECT Corporation 43.71 Million USD -94.675%
Supernus Pharmaceuticals, Inc. 529.01 Million USD 83.913%
Cronos Group Inc. 96.7 Million USD 12.002%
Ironwood Pharmaceuticals, Inc. 232.12 Million USD 63.338%
Kala Pharmaceuticals, Inc. 39.15 Million USD -117.358%
RedHill Biopharma Ltd. -9.56 Million USD 990.095%
Organogenesis Holdings Inc. 314.13 Million USD 72.909%
Guardion Health Sciences, Inc. 9.73 Million USD -774.56%
Cumberland Pharmaceuticals Inc. 43.04 Million USD -97.725%
Radius Health, Inc. 265.92 Million USD 67.998%
Universe Pharmaceuticals INC 13.84 Million USD -514.814%
ProPhase Labs, Inc. 37.85 Million USD -124.828%
Phibro Animal Health Corporation 260.29 Million USD 67.306%
Procaps Group S.A. 187.24 Million USD 54.55%
Alvotech 285.43 Million USD 70.185%
TherapeuticsMD, Inc. 9.82 Million USD -766.178%
Viatris Inc. 5.96 Billion USD 98.574%
Rockwell Medical, Inc. 15.37 Million USD -453.545%
Aytu BioPharma, Inc. 59.84 Million USD -42.216%
SIGA Technologies, Inc. 22.04 Million USD -286.072%
Tilray Brands, Inc. 251.35 Million USD 66.143%
Lifecore Biomedical, Inc. 49.03 Million USD -73.543%
Shineco, Inc. 17.94 Million USD -374.158%
PetIQ, Inc. 192.72 Million USD 55.843%
Regencell Bioscience Holdings Limited 3.99 Million USD -2032.274%
Incannex Healthcare Limited 30.05 Million USD -183.173%
Neurocrine Biosciences, Inc. 1.59 Billion USD 94.669%
Alimera Sciences, Inc. 62.64 Million USD -35.857%
Silver Spike Investment Corp. 762.49 Thousand USD -11061.035%
Assertio Holdings, Inc. 368.58 Million USD 76.911%
Shuttle Pharmaceuticals Holdings, Inc. 5.88 Million USD -1345.943%
Petros Pharmaceuticals, Inc. 17.8 Million USD -377.872%
Clever Leaves Holdings Inc. 21.16 Million USD -302.012%
Cyclo Therapeutics, Inc. 21.04 Million USD -304.437%
Avadel Pharmaceuticals plc 164.96 Million USD 48.412%
Hempacco Co., Inc. 7.59 Million USD -1020.287%
Talphera, Inc. 11.99 Million USD -609.538%
Alvotech 285.43 Million USD 70.185%
Eagle Pharmaceuticals, Inc. 140.71 Million USD 39.521%
Lantheus Holdings, Inc. 344.9 Million USD 75.326%
Currenc Group, Inc. 24 Million USD -254.561%
Kamada Ltd. 45.42 Million USD -87.342%
Indivior PLC 911 Million USD 90.658%
Evoke Pharma, Inc. 12.4 Million USD -585.773%
Flora Growth Corp. 10.57 Million USD -704.443%
Cyclo Therapeutics, Inc. 21.04 Million USD -304.437%
Evolus, Inc. 189.75 Million USD 55.153%
HUTCHMED (China) Limited 436.23 Million USD 80.492%
Amphastar Pharmaceuticals, Inc. 154.13 Million USD 44.787%
Akanda Corp. 3.48 Million USD -2342.997%